Results 191 to 200 of about 99,136 (277)

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry

open access: yes
American Journal of Hematology, Volume 101, Issue 2, Page 365-375, February 2026.
Jon Salmanton‐García   +95 more
wiley   +1 more source

Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM‐prognostic score (FCM‐PS) for overall survival

open access: yesHemaSphere, Volume 10, Issue 2, February 2026.
Abstract Flow cytometry (FCM) is a co‐criterion in myelodysplastic neoplasms (MDS) diagnostics, currently not used for prognostication. This study aimed to develop an FCM‐score predicting overall survival (OS) in MDS to improve early clinical patient prognostication.
Aida Santaolalla   +14 more
wiley   +1 more source

Immunophenotypic abnormality quantification refines multiparameter flow cytometry‐based measurable residual disease testing in adults allografted for acute myeloid leukemia in morphologic remission

open access: yesHemaSphere, Volume 10, Issue 2, February 2026.
Abstract Flow cytometry‐based measurable residual disease (MRD) testing is routinely used in acute myeloid leukemia (AML), but methodologies need refinement to optimize assay characteristics. Here, we examined 1215 adults with AML or myelodysplastic syndrome/AML allografted in morphologic remission to study how the type(s) of leukemic blasts and degree/
Calvin M. Le   +8 more
wiley   +1 more source

Outcomes of therapy‐related non‐core binding factor acute myeloid leukemia with venetoclax‐based therapies

open access: yesHemaSphere, Volume 10, Issue 2, February 2026.
Abstract Prognosis in therapy‐related acute myeloid leukemia (T‐AML) remains poor, but understanding outcomes with venetoclax (VEN)‐based therapy is relevant. We retrospectively analyzed 317 adult patients with newly diagnosed T‐AML focusing on lower intensity therapy (LIT) VEN‐containing regimens.
Jayastu Senapati   +21 more
wiley   +1 more source

Cytogenetic Abnormalities in Pediatric Myelodysplastic Syndrome: Insights on the Disease Biology and Impact on Leukemic Evolution. [PDF]

open access: yesBiomedicines
da Silva BF   +13 more
europepmc   +1 more source

Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Lower income European countries (LIECs) have more limited financial resources to cover high‐cost technologies in rare diseases than higher income European countries (HIECs). Our study explores how treatment recommendations in myelodysplastic syndrome (MDS) can be supported in LIECS by transferring real‐world evidence (RWE ...
Zoltán Kaló   +25 more
wiley   +1 more source

Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome. [PDF]

open access: yesNat Commun
Oshima M   +32 more
europepmc   +1 more source

Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohort. [PDF]

open access: yesJ Hematop
Patwardhan PP   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy